Antigen-presenting cells work to present peptides derived from exogenous and endogenous antigens to circulating T cells, sparking off an immune response. Dendritic cells are unique amongst antigen ...

A stable interaction between antigen-presenting cells (APC) and T cells is dependent not only on the absolute affinity between the T-cell receptor (TCR) and its ligand but also on the relative ...

Data from proof-of-concept studies of DPX-mRNA formulations conducted in collaboration with leading RNA technology company ...

The Swedish biotech hopes its precision therapy will help patients with advanced solid tumors who currently have few ...

In a news release, the company stated that the research highlights that DPX effectively recruits and activates unique subsets ...

SQZ Biotechnologies (NYSE:SQZ – Get Free Report) and Precision BioSciences (NASDAQ:DTIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...

You could target the aggressor T-cells directly. Or you could target the antigen presenting cell that orchestrates the immune attack." The ultimate goal, Cochrane said, would be a "living ...

These projects involve the production of plasmid DNA vaccines; the generation of genetically modified dendritic cells and genetically targeted T lymphocytes; as well as the engineering of artificial ...

Our research group aims at identification of cellular mechanisms, which could be used to enhance adaptive immune response in inflammation-associated disease conditions via controlled expansion of ...

The normal cornea contains a relatively small population of immune cells, which are mainly antigen-presenting cells, and lacks blood and lymph vessels. These qualities are partially responsible ...